Evidence map›Paper›PMID 30077634›Full record

ArticleCell systems2018

Quantitative Yeast Genetic Interaction Profiling of Bacterial Effector Proteins Uncovers a Role for the Human Retromer in Salmonella Infection.

Kristin L Patrick, Jason A Wojcechowskyj, Samantha L Bell, Morgan N Riba, Tao Jing, Sara Talmage, Pengbiao Xu, Ana L Cabello, Jiewei Xu, Michael Shales and 7 more

Abstract read
In one paragraph

Article in Cell systems, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. The retromer is co-opted to deliver lipid enzymes for the biogenesis of lipid-enriched tombusviral replication organelles.Proceedings of the National Academy of Sciences of the United States of America · 2021
    Article
  7. A systems approach to infectious disease.Nature reviews. Genetics · 2020
    Review
  8. Review
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Kristin L PatrickDepartment of Microbial Pathogenesis and Immunology, Texas A&M University Health Science Center, Bryan, TX 77802, USA.
Jason A WojcechowskyjDepartment of Cellular and Molecular Pharmacology, University of California, San Francisco, CA 94158, USA; Quantitative Biosciences Institute (QBI), University of California, San Francisco, CA 94158, USA; J. David Gladstone Institute, San Francisco, CA 94158, USA.
Samantha L BellDepartment of Microbial Pathogenesis and Immunology, Texas A&M University Health Science Center, Bryan, TX 77802, USA.
Morgan N RibaDepartment of Microbial Pathogenesis and Immunology, Texas A&M University Health Science Center, Bryan, TX 77802, USA.
Tao JingDepartment of Biochemistry and Biophysics, Texas A&M University, College Station, TX 77843, USA.
Sara TalmageDepartment of Microbial Pathogenesis and Immunology, Texas A&M University Health Science Center, Bryan, TX 77802, USA.
Pengbiao XuDepartment of Biochemistry and Biophysics, Texas A&M University, College Station, TX 77843, USA.
Ana L CabelloDepartment of Microbial Pathogenesis and Immunology, Texas A&M University Health Science Center, Bryan, TX 77802, USA; Department of Veterinary Pathobiology, Texas A&M College of Veterinary Medicine and Biomedical Sciences, College Station, TX 77843, USA; Norman Borlaug Center, Texas A&M University, College Station, TX 77843, USA.
Jiewei XuDepartment of Cellular and Molecular Pharmacology, University of California, San Francisco, CA 94158, USA; Quantitative Biosciences Institute (QBI), University of California, San Francisco, CA 94158, USA.
Michael ShalesDepartment of Cellular and Molecular Pharmacology, University of California, San Francisco, CA 94158, USA; Quantitative Biosciences Institute (QBI), University of California, San Francisco, CA 94158, USA.
David Jimenez-MoralesDepartment of Cellular and Molecular Pharmacology, University of California, San Francisco, CA 94158, USA; Quantitative Biosciences Institute (QBI), University of California, San Francisco, CA 94158, USA; J. David Gladstone Institute, San Francisco, CA 94158, USA.
Thomas A FichtDepartment of Veterinary Pathobiology, Texas A&M College of Veterinary Medicine and Biomedical Sciences, College Station, TX 77843, USA.
Paul de FigueiredoDepartment of Microbial Pathogenesis and Immunology, Texas A&M University Health Science Center, Bryan, TX 77802, USA; Department of Veterinary Pathobiology, Texas A&M College of Veterinary Medicine and Biomedical Sciences, College Station, TX 77843, USA; Norman Borlaug Center, Texas A&M University, College Station, TX 77843, USA.
James E SamuelDepartment of Microbial Pathogenesis and Immunology, Texas A&M University Health Science Center, Bryan, TX 77802, USA.
Pingwei LiDepartment of Biochemistry and Biophysics, Texas A&M University, College Station, TX 77843, USA.
Nevan J KroganDepartment of Cellular and Molecular Pharmacology, University of California, San Francisco, CA 94158, USA; Quantitative Biosciences Institute (QBI), University of California, San Francisco, CA 94158, USA; J. David Gladstone Institute, San Francisco, CA 94158, USA. Electronic address: nevan.krogan@ucsf.edu.
Robert O WatsonDepartment of Microbial Pathogenesis and Immunology, Texas A&M University Health Science Center, Bryan, TX 77802, USA. Electronic address: robert.watson@medicine.tamhsc.edu.

Funding

Using Networks to Seed Hierarchical Whole-cell Models of CancerU54CA209891 · NCI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI KROGAN, NEVAN J · 2017 to 2021
$10.9M
Comparative Analysis of Genetic Interaction NetworksR01GM084279 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI IDEKER, TREY, KROGAN, NEVAN J · 2008 to 2017
$3.9M
Identification and Role of Type IV Secretion Effector Proteins in Coxiella burnetiiR01AI090142 · NIAID · TEXAS A&M UNIVERSITY HEALTH SCIENCE CTR · PI SAMUEL, JAMES EVANS · 2012 to 2024
$3.4M
Discovery of novel, ubiquitin-regulated mechanisms of TB control by macrophagesR01AI120694 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI COX, JEFFERY S, KROGAN, NEVAN J · 2015 to 2019
$3.3M
Decoding the Chlamydia inclusion membrane protein-host protein interactomeR01AI122747 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI ENGEL, JOANNE N., KAAKE, ROBYN MIDORI · 2016 to 2020
$3.1M
Molecular basis of viral DNA sensing through the cGAS-STING pathwayR01AI145287 · NIAID · TEXAS A&M AGRILIFE RESEARCH · PI Pingwei Li · 2019 to 2026
$2.5M
Improved Live Attenuated Brucella Vaccines to Reduce Human DiseasesR01HD084339 · NICHD · TEXAS A&M AGRILIFE RESEARCH · PI FICHT, THOMAS A · 2015 to 2017
$1.8M
TRIM proteins polarize DNA sensing outcomes during the innate immune response to Mycobacterium tuberculosisR01AI125512 · NIAID · TEXAS A&M UNIVERSITY HEALTH SCIENCE CTR · PI WATSON, ROBERT OWEN · 2016 to 2019
$1.5M
The splicing factor SF3b1 is a master regulator of the innate immune response to Mycobacterium tuberculosisR21AI123753 · NIAID · TEXAS A&M UNIVERSITY HEALTH SCIENCE CTR · PI WATSON, ROBERT OWEN · 2016 to 2017
$408k
Harnessing Genetic Interactions to Uncover HIV-1 Rev Host FactorsF32AI116410 · NIAID · J. DAVID GLADSTONE INSTITUTES · PI WOJCECHOWSKYJ, JASON · 2015 to 2017
$173k
NCI NIH HHS U54 CA209891NIAID NIH HHS F32 AI116410NIAID NIH HHS R01 AI090142NIAID NIH HHS R01 AI120694NIAID NIH HHS R01 AI122747NIAID NIH HHS R01 AI125512NIAID NIH HHS R01 AI145287NIAID NIH HHS R21 AI123753NICHD NIH HHS R01 HD084339NIGMS NIH HHS R01 GM084279
6 · The paper itself

Abstract

Intracellular bacterial pathogens secrete a repertoire of effector proteins into host cells that are required to hijack cellular pathways and cause disease. Despite decades of research, the molecular functions of most bacterial effectors remain unclear. To address this gap, we generated quantitative genetic interaction profiles between 36 validated and putative effectors from three evolutionarily divergent human bacterial pathogens and 4,190 yeast deletion strains. Correlating effector-generated profiles with those of yeast mutants, we recapitulated known biology for several effectors with remarkable specificity and predicted previously unknown functions for others. Biochemical and functional validation in human cells revealed a role for an uncharacterized component of the Salmonella SPI-2 translocon, SseC, in regulating maintenance of the Salmonella vacuole through interactions with components of the host retromer complex. These results exhibit the power of genetic interaction profiling to discover and dissect complex biology at the host-pathogen interface.

Indexed as

AnimalsBacterial ProteinsGene Regulatory NetworksHeLa CellsHigh-Throughput Screening AssaysHost-Pathogen InteractionsHumansMiceMicroorganisms, Genetically-ModifiedMultiprotein ComplexesMutationSalmonella InfectionsSalmonella typhiSignal TransductionYeastsBacterial ProteinsMultiprotein ComplexesSseC protein, Salmonella typhimuriumbacterial effector proteinE-MAPgenetic interaction profilehost-pathogen interactionintracellular bacteriaretromer complexSalmonella enterica serovar Typhimurium

Identifiers

PMID30077634
PMCPMC6160342

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.